Cargando…
Immunometabolism in cancer at a glance
The scientific knowledge about tumor metabolism has grown at a fascinating rate in recent decades. We now know that tumors are highly active both in their metabolism of available nutrients and in the secretion of metabolic by-products. However, cancer cells can modulate metabolic pathways and thus a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124550/ https://www.ncbi.nlm.nih.gov/pubmed/30076128 http://dx.doi.org/10.1242/dmm.034272 |
_version_ | 1783353040392159232 |
---|---|
author | Singer, Katrin Cheng, Wan-Chen Kreutz, Marina Ho, Ping-Chih Siska, Peter J. |
author_facet | Singer, Katrin Cheng, Wan-Chen Kreutz, Marina Ho, Ping-Chih Siska, Peter J. |
author_sort | Singer, Katrin |
collection | PubMed |
description | The scientific knowledge about tumor metabolism has grown at a fascinating rate in recent decades. We now know that tumors are highly active both in their metabolism of available nutrients and in the secretion of metabolic by-products. However, cancer cells can modulate metabolic pathways and thus adapt to specific nutrients. Unlike tumor cells, immune cells are not subject to a ‘micro-evolution’ that would allow them to adapt to progressing tumors that continuously develop new mechanisms of immune escape. Consequently, immune cells are often irreversibly affected and may allow or even support cancer progression. The mechanisms of how tumors change immune cell function are not sufficiently explored. It is, however, clear that commonly shared features of tumor metabolism, such as local nutrient depletion or production of metabolic ‘waste’ can broadly affect immune cells and contribute to immune evasion. Moreover, immune cells utilize different metabolic programs based on their subtype and function, and these immunometabolic pathways can be modified in the tumor microenvironment. In this review and accompanying poster, we identify and describe the common mechanisms by which tumors metabolically affect the tumor-infiltrating cells of native and adaptive immunity, and discuss how these mechanisms may lead to novel therapeutic opportunities. |
format | Online Article Text |
id | pubmed-6124550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61245502018-09-07 Immunometabolism in cancer at a glance Singer, Katrin Cheng, Wan-Chen Kreutz, Marina Ho, Ping-Chih Siska, Peter J. Dis Model Mech At A Glance The scientific knowledge about tumor metabolism has grown at a fascinating rate in recent decades. We now know that tumors are highly active both in their metabolism of available nutrients and in the secretion of metabolic by-products. However, cancer cells can modulate metabolic pathways and thus adapt to specific nutrients. Unlike tumor cells, immune cells are not subject to a ‘micro-evolution’ that would allow them to adapt to progressing tumors that continuously develop new mechanisms of immune escape. Consequently, immune cells are often irreversibly affected and may allow or even support cancer progression. The mechanisms of how tumors change immune cell function are not sufficiently explored. It is, however, clear that commonly shared features of tumor metabolism, such as local nutrient depletion or production of metabolic ‘waste’ can broadly affect immune cells and contribute to immune evasion. Moreover, immune cells utilize different metabolic programs based on their subtype and function, and these immunometabolic pathways can be modified in the tumor microenvironment. In this review and accompanying poster, we identify and describe the common mechanisms by which tumors metabolically affect the tumor-infiltrating cells of native and adaptive immunity, and discuss how these mechanisms may lead to novel therapeutic opportunities. The Company of Biologists Ltd 2018-08-01 2018-08-02 /pmc/articles/PMC6124550/ /pubmed/30076128 http://dx.doi.org/10.1242/dmm.034272 Text en © 2018. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | At A Glance Singer, Katrin Cheng, Wan-Chen Kreutz, Marina Ho, Ping-Chih Siska, Peter J. Immunometabolism in cancer at a glance |
title | Immunometabolism in cancer at a glance |
title_full | Immunometabolism in cancer at a glance |
title_fullStr | Immunometabolism in cancer at a glance |
title_full_unstemmed | Immunometabolism in cancer at a glance |
title_short | Immunometabolism in cancer at a glance |
title_sort | immunometabolism in cancer at a glance |
topic | At A Glance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124550/ https://www.ncbi.nlm.nih.gov/pubmed/30076128 http://dx.doi.org/10.1242/dmm.034272 |
work_keys_str_mv | AT singerkatrin immunometabolismincancerataglance AT chengwanchen immunometabolismincancerataglance AT kreutzmarina immunometabolismincancerataglance AT hopingchih immunometabolismincancerataglance AT siskapeterj immunometabolismincancerataglance |